ArticleMolecular cancer therapeutics2025

Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers.

Mohd Mughees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.